Published in Implement Sci on October 13, 2008
Improving the reliability of clinical practice guideline appraisals: effects of the Korean AGREE II scoring guide. J Korean Med Sci (2014) 0.94
Assessment of the quality of clinical practice guidelines in Korea using the AGREE Instrument. J Korean Med Sci (2013) 0.92
Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ (1999) 14.34
Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care (2003) 12.01
Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA (1999) 8.97
Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet (2000) 8.10
Development and application of a generic methodology to assess the quality of clinical guidelines. Int J Qual Health Care (1999) 3.62
Towards evidence-based clinical practice: an international survey of 18 clinical guideline programs. Int J Qual Health Care (2003) 3.27
What is the quality of drug therapy clinical practice guidelines in Canada? CMAJ (2001) 3.15
A systematic review of appraisal tools for clinical practice guidelines: multiple similarities and one common deficit. Int J Qual Health Care (2005) 2.93
Facilitating the use of evidence in practice: evaluating and adapting clinical practice guidelines for local use by health care organizations. J Obstet Gynecol Neonatal Nurs (2002) 2.74
Reporting of conflicts of interest in guidelines of preventive and therapeutic interventions. BMC Med Res Methodol (2001) 2.38
Improving the quality of health care: using international collaboration to inform guideline programmes by founding the Guidelines International Network (G-I-N). Qual Saf Health Care (2004) 2.28
Improving the use of research evidence in guideline development: 13. Applicability, transferability and adaptation. Health Res Policy Syst (2006) 1.80
Improving the use of research evidence in guideline development: 4. Managing conflicts of interests. Health Res Policy Syst (2006) 1.56
The relation between systematic reviews and practice guidelines. Ann Intern Med (1997) 1.51
Reliability and validity of the AGREE instrument used by physical therapists in assessment of clinical practice guidelines. BMC Health Serv Res (2005) 1.49
Practice guidelines in Finland: availability and quality. Qual Health Care (1997) 1.21
Clinical guidelines: quantity without quality. Qual Health Care (1997) 1.21
Explaining inconsistencies between data on condom use and condom sales. BMC Health Serv Res (2005) 1.16
Assessment of the scope and quality of clinical practice guidelines in lung cancer. Chest (2003) 1.09
Guideline quality and guideline content: are they related? Clin Chem (2006) 1.05
Electronic primary care guidelines with links to Cochrane reviews--EBM Guidelines. Fam Pract (2005) 0.98
[Assessment of clinical practice guidelines evaluation. Scales and criteria]. Rev Esp Salud Publica (2004) 0.82
[Are the guidelines guiding us reliable? Evaluation of the Spanish clinical practice guidelines]. Rev Clin Esp (2005) 0.78
External validation of a measurement tool to assess systematic reviews (AMSTAR). PLoS One (2007) 2.70
Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr Rev (2002) 1.62
Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database Syst Rev (2013) 1.62
Major cardiovascular risk factors in Latin America: a comparison with the United States. The Latin American Consortium of Studies in Obesity (LASO). PLoS One (2013) 1.56
Noncommunicable diseases and injuries in Latin America and the Caribbean: time for action. PLoS Med (2006) 1.49
Prevalence of migraine in Latin America. Headache (2005) 1.25
Dengue vector dynamics (Aedes aegypti) influenced by climate and social factors in Ecuador: implications for targeted control. PLoS One (2013) 1.19
Clinical characteristics and patterns of medication use of migraneurs in Latin America from 12 cities in 6 countries. Headache (2005) 1.15
Smoking behavior and ethnicity in Jujuy, Argentina: evidence from a low-income youth sample. Subst Use Misuse (2009) 1.11
Relation between the global burden of disease and randomized clinical trials conducted in Latin America published in the five leading medical journals. PLoS One (2008) 1.09
[A census of medical genetics services in Argentina]. Rev Panam Salud Publica (2006) 0.98
[Right-to-health litigation in three Latin American countries: a systematic literature review]. Rev Panam Salud Publica (2013) 0.93
The Latin American Ongoing Clinical Trial Register (LATINREC). Rev Panam Salud Publica (2006) 0.93
Quality appraisal of clinical practice guidelines and consensus statements on the use of biologic agents in rheumatoid arthritis: a systematic review. Arthritis Rheum (2008) 0.93
Scope for improvement in the quality of reporting of systematic reviews. From the Cochrane Musculoskeletal Group. J Rheumatol (2005) 0.87
Chemoprophylaxis in contacts of patients with cholera: systematic review and meta-analysis. PLoS One (2011) 0.84
[The cost-utility ratio of reducing salt intake and its impact on the incidence of cardiovascular disease in Argentina]. Rev Panam Salud Publica (2012) 0.82
Poor reporting of search strategy and conflict of interest in over 250 narrative and systematic reviews of two biologic agents in arthritis: a systematic review. J Clin Epidemiol (2008) 0.82
[Knowledge, perceptions, and behavior related to salt consumption, health, and nutritional labeling in Argentina, Costa Rica, and Ecuador]. Rev Panam Salud Publica (2012) 0.81
The new United Nations approach to sustainable development post-2015: Findings from four overviews of systematic reviews on interventions for sustainable development and health. Rev Panam Salud Publica (2016) 0.80
Clinical trial regulation in Argentina: overview and analysis of regulatory framework, use of existing tools, and researchers' perspectives to identify potential barriers. Rev Panam Salud Publica (2011) 0.80
[Detection of domestic violence against women. Survey in a primary health care clinic]. Medicina (B Aires) (2004) 0.79
Smoking and exposure to racial insults among multiethnic youth in Jujuy, Argentina. Cancer Causes Control (2012) 0.78
[Researching and publishing in public health in Argentina]. Medicina (B Aires) (2004) 0.77
[Health literacy in patients attending a University Hospital]. Medicina (B Aires) (2009) 0.76
Evidence-based medicine in Iberoamerica: problems and possible solutions. PLoS Med (2005) 0.76
[Physician-patient relationship, scientific medicine and alternative therapies]. Medicina (B Aires) (2004) 0.75
Oxytocin for preventing postpartum haemorrhage (PPH) in non-facility birth settings. Cochrane Database Syst Rev (2016) 0.75
Energy interventions that facilitate sustainable development and impact health: an overview of systematic reviews. Rev Panam Salud Publica (2016) 0.75
Predictors of antibiotic prescription in respiratory tract infections by ambulatory care practitioners. Medicina (B Aires) (2005) 0.75
[To improve the quality of the studies is to improve the quality of the journal]. Acta Gastroenterol Latinoam (2006) 0.75
Interventions that facilitate sustainable development by preventing toxic exposure to chemicals: an overview of systematic reviews. Rev Panam Salud Publica (2016) 0.75
[Cost-benefit of a prevention and treatment program to reduce iron deficiency in Argentina]. Rev Panam Salud Publica (2009) 0.75
Agriculture, food, and nutrition interventions that facilitate sustainable food production and impact health: an overview of systematic reviews. Rev Panam Salud Publica (2016) 0.75
[Surveillance of health care errors. An overview of the published data in Argentina]. Medicina (B Aires) (2006) 0.75
[Availability of indicators for monitoring the achievement of "Universal Health" in Latin America and the Caribbean]. Rev Panam Salud Publica (2016) 0.75